KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Basic) (2016 - 2025)

Johnson & Johnson's EPS (Basic) history spans 17 years, with the latest figure at $2.12 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 49.3% year-over-year to $2.12; the TTM value through Dec 2025 reached $11.13, up 90.58%, while the annual FY2025 figure was $11.13, 90.58% up from the prior year.
  • EPS (Basic) for Q4 2025 was $2.12 at Johnson & Johnson, down from $2.14 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $4.57 in Q1 2025 and bottomed at -$0.19 in Q2 2023.
  • The 5-year median for EPS (Basic) is $1.77 (2022), against an average of $1.73.
  • The largest YoY upside for EPS (Basic) was 1610.0% in 2023 against a maximum downside of 109.69% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at $1.39 in 2021, then grew by 22.3% to $1.7 in 2022, then increased by 0.59% to $1.71 in 2023, then decreased by 16.96% to $1.42 in 2024, then surged by 49.3% to $2.12 in 2025.
  • Per Business Quant, the three most recent readings for JNJ's EPS (Basic) are $2.12 (Q4 2025), $2.14 (Q3 2025), and $2.3 (Q2 2025).